174 related articles for article (PubMed ID: 32820031)
1. Cercosporamide inhibits bone morphogenetic protein receptor type I kinase activity in zebrafish.
Hoeksma J; van der Zon GCM; Ten Dijke P; den Hertog J
Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32820031
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors.
Sanchez-Duffhues G; Williams E; Goumans MJ; Heldin CH; Ten Dijke P
Bone; 2020 Sep; 138():115472. PubMed ID: 32522605
[TBL] [Abstract][Full Text] [Related]
3. Dynamic analysis of BMP-responsive smad activity in live zebrafish embryos.
Laux DW; Febbo JA; Roman BL
Dev Dyn; 2011 Mar; 240(3):682-94. PubMed ID: 21337466
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis.
Little SC; Mullins MC
Nat Cell Biol; 2009 May; 11(5):637-43. PubMed ID: 19377468
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
Liu Y; Sun L; Su X; Guo S
Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
[TBL] [Abstract][Full Text] [Related]
6. A new class of small molecule inhibitor of BMP signaling.
Sanvitale CE; Kerr G; Chaikuad A; Ramel MC; Mohedas AH; Reichert S; Wang Y; Triffitt JT; Cuny GD; Yu PB; Hill CS; Bullock AN
PLoS One; 2013; 8(4):e62721. PubMed ID: 23646137
[TBL] [Abstract][Full Text] [Related]
7. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P
J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
[TBL] [Abstract][Full Text] [Related]
8. Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling.
Xie C; Jiang W; Lacroix JJ; Luo Y; Hao J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899497
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
10. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism.
Yu PB; Hong CC; Sachidanandan C; Babitt JL; Deng DY; Hoyng SA; Lin HY; Bloch KD; Peterson RT
Nat Chem Biol; 2008 Jan; 4(1):33-41. PubMed ID: 18026094
[TBL] [Abstract][Full Text] [Related]
11. ALK2: A Therapeutic Target for Fibrodysplasia Ossificans Progressiva and Diffuse Intrinsic Pontine Glioma.
Sekimata K; Sato T; Sakai N
Chem Pharm Bull (Tokyo); 2020; 68(3):194-200. PubMed ID: 32115526
[TBL] [Abstract][Full Text] [Related]
12. Variant BMP receptor mutations causing fibrodysplasia ossificans progressiva (FOP) in humans show BMP ligand-independent receptor activation in zebrafish.
Mucha BE; Hashiguchi M; Zinski J; Shore EM; Mullins MC
Bone; 2018 Apr; 109():225-231. PubMed ID: 29307777
[TBL] [Abstract][Full Text] [Related]
13. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD
J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401
[TBL] [Abstract][Full Text] [Related]
14. Long-chain Acyl-CoA synthetase 4A regulates Smad activity and dorsoventral patterning in the zebrafish embryo.
Miyares RL; Stein C; Renisch B; Anderson JL; Hammerschmidt M; Farber SA
Dev Cell; 2013 Dec; 27(6):635-47. PubMed ID: 24332754
[TBL] [Abstract][Full Text] [Related]
15. Development of an ALK2-biased BMP type I receptor kinase inhibitor.
Mohedas AH; Xing X; Armstrong KA; Bullock AN; Cuny GD; Yu PB
ACS Chem Biol; 2013; 8(6):1291-302. PubMed ID: 23547776
[TBL] [Abstract][Full Text] [Related]
16. In vivo analysis using variants of zebrafish BMPR-IA: range of action and involvement of BMP in ectoderm patterning.
Nikaido M; Tada M; Takeda H; Kuroiwa A; Ueno N
Development; 1999 Jan; 126(1):181-90. PubMed ID: 9834197
[TBL] [Abstract][Full Text] [Related]
17. Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva.
Fukuda T; Kohda M; Kanomata K; Nojima J; Nakamura A; Kamizono J; Noguchi Y; Iwakiri K; Kondo T; Kurose J; Endo K; Awakura T; Fukushi J; Nakashima Y; Chiyonobu T; Kawara A; Nishida Y; Wada I; Akita M; Komori T; Nakayama K; Nanba A; Maruki Y; Yoda T; Tomoda H; Yu PB; Shore EM; Kaplan FS; Miyazono K; Matsuoka M; Ikebuchi K; Ohtake A; Oda H; Jimi E; Owan I; Okazaki Y; Katagiri T
J Biol Chem; 2009 Mar; 284(11):7149-56. PubMed ID: 18684712
[TBL] [Abstract][Full Text] [Related]
18. A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor.
Fukuda T; Kanomata K; Nojima J; Kokabu S; Akita M; Ikebuchi K; Jimi E; Komori T; Maruki Y; Matsuoka M; Miyazono K; Nakayama K; Nanba A; Tomoda H; Okazaki Y; Ohtake A; Oda H; Owan I; Yoda T; Haga N; Furuya H; Katagiri T
Biochem Biophys Res Commun; 2008 Dec; 377(3):905-9. PubMed ID: 18952055
[TBL] [Abstract][Full Text] [Related]
19. Reduced GS Domain Serine/Threonine Requirements of Fibrodysplasia Ossificans Progressiva Mutant Type I BMP Receptor ACVR1 in the Zebrafish.
Allen RS; Jones WD; Hale M; Warder BN; Shore EM; Mullins MC
J Bone Miner Res; 2023 Sep; 38(9):1364-1385. PubMed ID: 37329499
[TBL] [Abstract][Full Text] [Related]
20. SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1.
Raju GP; Dimova N; Klein PS; Huang HC
J Biol Chem; 2003 Jan; 278(1):428-37. PubMed ID: 12393873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
